PL4021433T3 - Leczenie objawów wywołanych cyklem menstruacyjnym - Google Patents

Leczenie objawów wywołanych cyklem menstruacyjnym

Info

Publication number
PL4021433T3
PL4021433T3 PL20772102.8T PL20772102T PL4021433T3 PL 4021433 T3 PL4021433 T3 PL 4021433T3 PL 20772102 T PL20772102 T PL 20772102T PL 4021433 T3 PL4021433 T3 PL 4021433T3
Authority
PL
Poland
Prior art keywords
treatment
symptoms caused
menstruation cycle
menstruation
cycle
Prior art date
Application number
PL20772102.8T
Other languages
English (en)
Inventor
Merel JANSSEN
Edgar Stijn Jochem JANSSEN
Ezekiel Golan
Original Assignee
Period Pill Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Period Pill Bv filed Critical Period Pill Bv
Publication of PL4021433T3 publication Critical patent/PL4021433T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PL20772102.8T 2019-08-26 2020-08-26 Leczenie objawów wywołanych cyklem menstruacyjnym PL4021433T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962891438P 2019-08-26 2019-08-26
PCT/IB2020/057967 WO2021038460A1 (en) 2019-08-26 2020-08-26 Treatment of menstrual cycle-induced symptoms

Publications (1)

Publication Number Publication Date
PL4021433T3 true PL4021433T3 (pl) 2024-03-11

Family

ID=72517274

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20772102.8T PL4021433T3 (pl) 2019-08-26 2020-08-26 Leczenie objawów wywołanych cyklem menstruacyjnym

Country Status (17)

Country Link
US (2) US11559502B2 (pl)
EP (1) EP4021433B1 (pl)
JP (1) JP7638967B2 (pl)
KR (1) KR20220069014A (pl)
CN (1) CN114555070B (pl)
AU (1) AU2020335372B2 (pl)
BR (1) BR112022003686A2 (pl)
CA (1) CA3152069A1 (pl)
ES (1) ES2967484T3 (pl)
HR (1) HRP20231735T1 (pl)
HU (1) HUE064596T2 (pl)
IL (1) IL290880B1 (pl)
MA (1) MA56998B1 (pl)
MX (1) MX2022002400A (pl)
PL (1) PL4021433T3 (pl)
WO (1) WO2021038460A1 (pl)
ZA (1) ZA202203367B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20231735T1 (hr) 2019-08-26 2024-03-15 Period Pill Bv Liječenje simptoma izazvanih menstrualnim ciklusom
WO2025022362A1 (en) * 2023-07-27 2025-01-30 Clearmind Medicine Inc. Compositions and methods for treating dyskinesia
WO2025196662A1 (en) * 2024-03-20 2025-09-25 Clearmind Labs Corp. Compositions and methods for treating eating disorders

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389670A (en) 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
EP1517667A2 (en) 2002-07-02 2005-03-30 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20040127409A1 (en) 2002-11-07 2004-07-01 Milkhaus Laboratory, Inc. Method of treatment of psychological conditions by administration of nerve growth factor
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
WO2006012563A2 (en) 2004-07-23 2006-02-02 The Regents Of The University Of California Method for the treatment and diagnosis of certain psychiatric disorders related to the menstrual cycle
US20080262071A1 (en) 2004-09-17 2008-10-23 Timothy Dinan Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
JP2008538748A (ja) * 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド 不安、物質乱用及び依存の予防のための改良型方法及び組成物
TW200718692A (en) 2005-04-22 2007-05-16 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
CA2605580A1 (en) 2005-04-22 2006-11-02 Wyeth Benzodioxane and benzodioxolane derivatives and uses thereof
US20070098819A1 (en) 2005-11-02 2007-05-03 Susan Thys-Jacobs Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks
US20070255278A1 (en) 2006-04-28 2007-11-01 Nobis Rudolph H Apparatus and method for deploying a cutting element during an endoscopic mucosal resection
US20080160083A1 (en) 2007-01-03 2008-07-03 Jarret Morrow Composition and method for treatment of premenstrual symptoms
MX2011001384A (es) 2008-08-06 2011-09-27 Gosforth Ct Holdings Pty Ltd Composiciones y metodos para tratar trastornos psiquiatricos.
WO2010054286A2 (en) 2008-11-10 2010-05-14 Auspex Pharmaceuticals, Inc. Substituted hydroxyphenylamine compounds
US9119865B2 (en) 2009-10-27 2015-09-01 Lipogen Ltd. Compositions and methods for alleviating symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
WO2013171146A1 (en) * 2012-05-15 2013-11-21 Lts Lohmann Therapie-Systeme Ag Oral film containing enteric release opiate resinate
BR102013013564A2 (pt) 2013-05-31 2015-07-07 Ems Sa Composição para tratamento ou redução de sintomas relacionados à tensão pré-menstrual (tpm), transtorno disfórico pré-menstrual (tdpm), pré-menopausa, menopausa ou desordens hormonais femininas, forma farmacêutica contendo dita composição, processo para produzir dita forma farmacêutica e uso de dita composição
KR102262306B1 (ko) 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
US10575829B2 (en) 2014-09-03 2020-03-03 Earlysense Ltd. Menstrual state monitoring
TWI774660B (zh) 2016-03-08 2022-08-21 日商大塚製藥股份有限公司 女性特有之身體及/或精神不快症狀之改善劑
WO2018125019A2 (en) * 2016-12-30 2018-07-05 Istanbul Üni̇versi̇tesi̇ Use of some mirnas for the diagnosis and treatment of diseases associated with insulin
WO2019026019A1 (en) 2017-08-03 2019-02-07 Therapeutic Adjuncts Inc. USE OF 3-METHYLMETHCATHINONE
HRP20231735T1 (hr) 2019-08-26 2024-03-15 Period Pill Bv Liječenje simptoma izazvanih menstrualnim ciklusom

Also Published As

Publication number Publication date
CN114555070A (zh) 2022-05-27
AU2020335372B2 (en) 2025-07-03
IL290880B1 (en) 2026-03-01
MA56998B1 (fr) 2023-12-29
EP4021433C0 (en) 2023-10-04
US11559502B2 (en) 2023-01-24
HRP20231735T1 (hr) 2024-03-15
CA3152069A1 (en) 2021-03-04
EP4021433A1 (en) 2022-07-06
BR112022003686A2 (pt) 2022-05-24
US12485100B2 (en) 2025-12-02
CN114555070B (zh) 2024-11-05
ES2967484T3 (es) 2024-04-30
JP7638967B2 (ja) 2025-03-04
IL290880A (en) 2022-04-01
AU2020335372A1 (en) 2022-04-07
KR20220069014A (ko) 2022-05-26
EP4021433B1 (en) 2023-10-04
JP2022545960A (ja) 2022-11-01
US20220265581A1 (en) 2022-08-25
ZA202203367B (en) 2023-10-25
US20230145635A1 (en) 2023-05-11
WO2021038460A1 (en) 2021-03-04
MX2022002400A (es) 2022-06-08
HUE064596T2 (hu) 2024-03-28

Similar Documents

Publication Publication Date Title
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
EP3370703A4 (en) GEMCABEN COMBINATIONS FOR TREATING HEART CIRCULATION DISEASES
LT3740504T (lt) Cd70 kompleksinė terapija
MA47820A (fr) Traitement de la glycogénose de type iii
IL290880A (en) Treatment of menstrual cycle-induced symptoms
IL282311A (en) Use of reboxetine to treat narcolepsy
EP4076217A4 (en) SYNDESMOSIS TREATMENT CONSTRUCT
PL3592355T3 (pl) Kx2-391/kx-01 do zastosowania w leczeniu rogowacenia słonecznego
IL289592A (en) Methods for diagnosing the effectiveness of anti-tumor treatment
EP3999100C0 (en) ENHANCED TREATMENT WITH EYP001
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
EP3962524A4 (en) CANCER TREATMENT
EP3873528A4 (en) Rasopathy treatment
IL280968A (en) Combination therapy
IL282407A (en) Nanocarriers for lung inflammation therapy
EP3741338C0 (de) Tampon
EP4062884A4 (en) DISPOSABLE DIAPER
EP3616721A4 (en) BLOOD PURIFICATION PROCESS USING AN ALKALINIZING AGENT
EP4005489A4 (en) Stethoscope
IL288237A (en) Combination therapy
IL290747A (en) Therapeutic conjugate
DK3967284T3 (da) Engangsble
DK4009942T3 (da) Forbindelse til kombinationsbehandling
EP3960307A4 (en) TREATMENT LIQUID
EP3988334A4 (en) TIRES